Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

SUNSTONE LIFE SCIENCE VENTURES FUND II K/S - Group Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmarkIFRS Analyst: XBRLDenmarkIFRS

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.3% 0.3%   Bankruptcy risk   3.2% 1.4% 0.8% 3.8% 3.6% 4.1% 17.1% 17.1%   Credit score (0-100)   57 80 90 50 52 48 10 10   Credit rating   BBB A A BBB BBB BBB BB BB   Credit limit (kDKK)   0.0 3,181.2 38,424.8 0.0 0.0 0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   -85,098 -8,592 68,062 0.0 0.0 0.0 0.0 0.0   EBITDA   -85,478 -10,248 66,930 -189,028 -74,773 -37,902 0.0 0.0   EBIT   -85,478 -10,248 66,930 -189,028 -74,773 -37,902 0.0 0.0   Pre-tax profit (PTP)   -85,519.0 -10,265.0 66,919.0 -189,039.0 -74,775.0 -37,870.0 0.0 0.0   Net earnings   -85,519.0 -10,265.0 66,919.0 -189,039.0 -74,775.0 -37,870.0 0.0 0.0   Pre-tax profit without non-rec. items   -85,519 -10,265 66,919 -189,039 -74,775 -37,870 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   385,634 377,438 440,171 146,065 71,290 22,390 -412,390 -412,390   Interest-bearing liabilities   0.0 0.0 0.0 0.0 0.0 0.0 412,390 412,390   Balance sheet total (assets)   385,734 379,060 440,264 146,138 71,364 22,464 0.0 0.0   Net Debt   -6,991 -880 -1,163 -1,007 -2,853 -11.6 412,390 412,390     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   -85,098 -8,592 68,062 0.0 0.0 0.0 0.0 0.0   Gross profit growth   61.9% 89.9% 0.0% -100.0% 0.0% 0.0% 0.0% 0.0%   Employees   0 0 0 0 0 0 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   385,734 379,060 440,264 146,138 71,364 22,464 0 0   Balance sheet change%   -21.1% -1.7% 16.1% -66.8% -51.2% -68.5% -100.0% 0.0%   Added value   -85,478.0 -10,248.0 66,930.0 -189,028.0 -74,773.0 -37,902.0 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -2.0 -3.0 1.0 -1.0 -2.0 -3.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   100.4% 119.3% 98.3% 0.0% 0.0% 0.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -19.5% -2.7% 16.3% -64.5% -68.8% -80.7% 0.0% 0.0%   ROI %   -19.5% -2.7% 16.4% -64.5% -68.8% -80.8% 0.0% 0.0%   ROE %   -19.6% -2.7% 16.4% -64.5% -68.8% -80.8% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   100.0% 99.6% 100.0% 100.0% 99.9% 99.7% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   8.2% 8.6% -1.7% 0.5% 3.8% 0.0% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   70.6 0.5 12.5 13.8 38.6 157.4 0.0 0.0   Current Ratio   70.6 0.5 12.5 13.8 38.6 157.4 0.0 0.0   Cash and cash equivalent   6,991.0 880.0 1,163.0 1,007.0 2,853.0 11.6 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   6,892.0 -742.0 1,070.0 934.0 2,779.0 11,574.0 -206,195.0 -206,195.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 0 0 0   EBIT / employee   0 0 0 0 0 0 0 0   Net earnings / employee   0 0 0 0 0 0 0 0